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Summary
Purpose: To assess the advantages of the 2001 ILAE proposed diagnostic scheme for
classification of newborns with epileptic seizures over the 1989 ILAE classification.
Method: Clinical features, seizure semiology and duration, neurological evaluation,
ictal and interictal EEG, brain imaging and outcome at the end of the neonatal period
(44 weeks post-conceptional age) of 94 newborns with EEG confirmed seizures were
analyzed. The 2001 ILAE classification was applied where possible.
Results: Twenty patients died before the end of the neonatal period. In the remaining
patients, applying axis 3, we classified 54 newborns as having epileptic seizures that
do not require a diagnosis of epilepsy; 14 as symptomatic partial epilepsy; 5 within the
neonatal epileptic syndromes and one as benign neonatal seizures (NS). Axis 4 in all
newborns provided a valuable tool in order to better define the individual patient.
Conclusions: Compared to the 1989 ILAE classification, which allowed a syndromic
diagnosis in only 6/94 patients, the remaining being classified as Epilepsies and
Syndromes undetermined whether focal or generalized, the 2001 ILAE diagnostic
scheme, applied at the end of the neonatal period, offers a variety of approaches to
classification, allowing an early distinction between epilepsy and single or isolated
clusters of seizures, with therapeutic and prognostic implications.
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Seizures are the most frequent clinical sign of neu-
rological dysfunction in the neonate.1—5 The major-
ity are occasional seizures, occurring as reactive
events to acute insults, systemic diseases or distur-
bances, and subsiding soon after removal of the
causative event. A significant percentage of neona-
tal seizures (NS), however, are symptoms of severe
or progressive brain disease and prelude to devel-
opment of neurological deterioration and epilepsy.
Prediction of outcome and definition of therapy,
especially long-term, is complicated by the lack
of a standardized terminology and classification.4
The 1989 ILAE classification of epilepsy and epi-
leptic syndromes6 was found unsatisfactory in new-
borns.7,8 According to it, most of NS are classified
under epilepsies and syndromes undetermined
whether focal or generalized, with the exception
of four rare but well defined electro-clinical syn-
dromes: early myoclonic encephalopathy (EME),
early infantile epileptic encephalopathy (EIEE),
benign idiopathic neonatal convulsions (BINNC),
benign familial neonatal convulsions (BFNNC). The
2001 ILAE proposed diagnostic scheme for people
with epileptic seizures and with epilepsy9 offers a
variety of approaches to classification increasing its
power to characterize individual patients in a less
ambiguous manner with clear etiologic, therapeutic
and prognostic implications.
We analyzed electro-clinical parameters at the
onset of seizures and at the end of the neonatal
period of 94 newborns with EEG confirmed NS, born
from 1990 to 1998 and followed from birth, classify-
ing them according to the 2001 ILAE new proposal.9
Aim of this study was to assess whether the 2001
proposed diagnostic scheme proves more useful
than the 1989 ILAE classification to recognize, by
the end of the neonatal period, syndromes with a
common electro-clinical course.2. Patients and methods
From January 1990 to December 1998, all newborns
admitted to the Neonatal Intensive Care Unit (NICU)
of Mangiagalli Hospital (Milan) with suspected NS, at
high risk of developing seizures, or pharmacologi-
cally paralyzed for ventilation were referred to the
Neurological—Neurophysiological Unit of the same
Hospital for investigation. Monitoring was usually
provided within an hour (range 20 min—3 h). A total
of 298 infants underwent EEG recordings. Of these,
94 showed electrographic seizures, with or without
clinical manifestations, and were included in this
study. Infants with clinical only paroxysmal eventswhose seizures were not accompanied by EEG sei-
zure activity were excluded.5,10,11
Neonatal bedside EEG recordings were obtained
with an Alvar 16-channel machine, using the Inter-
national 10—20 system of electrode placement mod-
ified for neonates. All recordings were obtained at
15 mm/s paper speed with a typical sensitivity of
7 mV/mm and a time constant of 0.3 s. Electro-
oculogram, electro-myogram, EKG and respiration
were also recorded.
The specially trained technologists remained at
bedside throughout the recording and marked on
the running paper any unusual event. Records lasted
at least 60 min, but could last 2 h andmore andwere
repeated several times in infants with multiple
seizures, in critically ill or paralyzed infants and
in those with apparently clinical-only seizures or
electrographic seizures.
Electro-clinical and electrographic seizures were
detected by visual analysis of EEG tracings and were
considered to exist if they lasted a minimum of
10 s11 and exhibited a typical evolution in space
and time of abnormal repetitive stereotyped wave-
forms.
Standard workout towards an etiologic diagnosis
involved evaluation of clinical parameters (familial
history, gestational age, quality of intrauterine
growth, Apgar score and need for resuscitation at
birth, cord blood pH and BE, seizure type and dura-
tion, neurological evaluation, basic infective and
metabolic assessment), ictal and interictal EEG
characteristics and brain imaging (US scans, CT or
MRI).
Seizures were classified according to Volpe5 as
clonic focal/multifocal, tonic focal/generalized,
myoclonic focal/multifocal/generalized and subtle,
adding the category ‘‘spasms’’ according to Mizrahi
and Kellaway.10
Neurological evaluation, based on mental status,
tone and motor activity, according to Clancy and
Legido,11 was defined as normal, mildly/moderately
abnormal, severely abnormal. Pharmacologically
paralyzed infants were classified as ‘‘not assessa-
ble’’.
The EEG parameters considered were interictal
background, seizure duration, type of seizure (elec-
trical/electroclinical). EEG background was classi-
fied as normal, moderately abnormal, severely
abnormal.12 Inactive records were considered as
severely abnormal. Seizure duration was arbitrarily
subdivided, for the purposes of the study, into less
than 1 min; more than 1 min but less than 30 min,
more than 30 min but less than 1 day; more than 1
day. Seizures lasting more than 30 min or recurrent
for more than 50% of the entire recording time were
classified as neonatal epileptic status.13 Whenever
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Table 1 Neurological examination, EEG characteristics, US scan findings, MRI/CTscan findings and etiology in the 94
patients.
Pt Neurol EEG Ultrasound CT/MRI Etiology
15 S m PV hyperechogenicity Bitemporal necrosis CNS infection
18 S s PV hyperechogenicity PV leukomalacia CNS infection
21 S s PV hyperechogenicity \ CNS infection
36 U m PV hyperechogenicity \ CNS infection
50 U n PV hyperechogenicity \ CNS infection
51 S m n \ CNS infection
55 M s n N CNS infection
65 S m PV hyperechogenicity,
IV haemorrhage
\ CNS infection
86 S m PV hyperechogenicity,
mixed cystic leukomalacia
Diffuse PV leukomalacia CNS infection
90 S s Edema Edema CNS infection
25 S s n Cortical dysplasia CNS malformation
36 N m Focal hyperechogenicity Tuberous sclerosis CNS malformation
49 S s Malformation Lissencephaly CNS malformation
52 M s n Frontotemporal polymicrogyria CNS malformation
56 M s Hemimegaloencephaly Hemimegaloencephaly CNS malformation
69 S s Malformation Teratoma CNS malformation
74 N m Ventricular dilatation Teratoma CNS malformation
75 S s Ventricular dilatation Lissencephaly CNS malformation
84 M s Unilateral malformation Complex unilateral
malformation
CNS malformation
30 S s PV hyperechogenicity PV leukomalacia, atrophy Cryptogenetic
45 M m n N Cryptogenetic
46 S s PV hyperechogenicity Atrophy Cryptogenetic
64 S s n N Cryptogenetic
89 S s n N Cryptogenetic
3 S s IV, IP haemorrhage \ HIE
4 S s PV hyperechogenicity PV leukomalacia HIE
5 M m PV hyperechogenicity PV leukomalacia HIE
9 S s Ventricular dilatation,
PV hyperechogenicity
PV leukomalacia,
ventricular dilatation
HIE
11 U s PV hyperechogenicity,
IV haemorrhage
Porencephaly HIE
17 S s PV hyperechogenicity SA haemorrhage,
biopercular malacia
HIE
22 S s PV hyperechogenicity Multicystic encephalopathy HIE
26 U m Ventricular dilatation PV leukomalacia, atrophy HIE
27 S s Edema Arachnoid cyst HIE
28 U m n N HIE
29 S s PV hyperechogenicity PV leukomalacia, atrophy HIE
31 U s PV hyperechogenicity Diffuse PV leukomalacia HIE
32 S m Porencephaly PV leukomalacia, porencephaly HIE
38 S s PV hyperechogenicity Diffuse PV leukomalacia HIE
39 S s PV hyperechogenicity \ HIE
40 S s Porencephaly Diffuse PV leukomalacia,
ventricular dilatation
HIE
41 U m PV hyperechogenicity PV leukomalacia HIE
43 S s Mixed cystic leukomalcia,
atrophy
PV leukomalacia, atrophy HIE
44 S m PV hyperechogenicity \ HIE
48 U s n \ HIE
53 U s n \ HIE
57 S s Mixed cystic leukomalacia Subependimal haemorrhage,
atrophy
HIE
60 S s Hydrocephaly \ HIE
61 S s PV hyperechogenicity Diffuse PV leukomalacia,
porencephaly
HIE
62 U m PV hyperechogenicity Diffuse PV leukomalacia,
porencephaly
HIE
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Table 1 (Continued )
Pt Neurol EEG Ultrasound CT/MRI Etiology
63 U s PV hyperechogenicity Diffuse PV leukomalacia,
porencephaly
HIE
66 U s IV/IP haemorrhage Multicystic encephalopathy HIE
67 S s PV hyperechogenicity Porencephaly HIE
68 U s Edema \ HIE
70 S s PV hyperechogenicity,
porencephaly
PV leukomalacia, porencephaly HIE
71 S s Edema \ HIE
72 S m PV hyperechogenicity,
IV haemorrhage
\ HIE
76 S s Mixed cystic leukomalcia Multicystic encephalopathy HIE
79 S s IV haemorrhage,
PV hyperechogenicity
Diffuse PV leukomalacia HIE
80 M m n \ HIE
81 U s PV hyperechogenicity,
SE haemorrhage
Leukomalacia, porencephaly HIE
87 U s Edema Diffuse PV leukomalacia HIE
88 S s Ventricular dilatation,
atrophy
Diffuse PV leukomalacia HIE
91 S s IV intraparenchymal
haemorrhage
Multicystic encephalopathy HIE
95 U s PV hyperechogenicity,
edema
\ HIE
10 S m IV haemorrhage,
hydrocephaly
IV haemorrhage,
hydrocephaly
HIE
35 S s Ventricular dilatation,
PV hyperechogenicity
Diffuse PV leukomalacia,
porencephaly
HIE
19 N m n N Idiopathic
12 S s Edema Atrophy Metabolic
14 M s n N Metabolic
77 M m Focal hyperechogenicity Focal ischemia Metabolic
78 S s IP haemorrhage IP haemorrhage Metabolic
82 M m n \ Metabolic
83 U s edema \ Metabolic
94 S s n \ Metabolic
6 M m IP haemorrhage IP haemorrhage Stroke
7 N m n Focal ischemia Stroke
8 N n Focal hyperechogenicity Focal ischemia Stroke
16 N m Focal hyperechogenicity Focal ischemia Stroke
24 N m Focal PV hyperechogenicity Focal ischemia Stroke
47 M s Focal hyperechogenicity Focal ischemia Stroke
54 U s Edema Focal ischemia, atrophy Stroke
13 M s Atrophy Atrophy Transitory acute hypoxia
23 S m SA haemorrhage SA haemorrhage Transitory acute hypoxia
33 M m Ventricular dilatation \ Transitory acute hypoxia
42 M m n \ Transitory acute hypoxia
58 U m Ventricular dilatation \ Transitory acute hypoxia
93 U s Edema \ Transitory acute hypoxia
73 M m n \ Transitory metabolic
59 S s n \ Transitory metabolic
92 M m n \ Transitory metabolic
2 M m IV haemorrhage SE haemorrhage Vascular
20 S m PV hyperechogenicity,
IV/IP haemorrhage
\ Vascular
34 S s IV haemorrhage \ Vascular
85 S s Hydrocephaly Hydrocephaly,
PV leukomalacia
Vascular
N, normal; m, moderately abnormal; s, severely abnormal; PV, periventricular; IV, intraventricular; SE, subependimal; SA,
subarachnoid; IP, intraparenchymal; HIE, hypoxic—ischaemic.
308 M. Mastrangelo et al.possible, EEGmonitoring was performed prior to the
beginning of therapy.
Ultrasonography was performed in all newborns
with NS. CT/MRI of the brain was performed in 66
patients.
Hypoxic ischaemic encephalopathy (HIE) was diag-
nosed according to the criteria of the American Col-
lege of Obstetricians and Gynecologists (ACOG) for
neonatal asphyxia.14 We called transitory acute
hypoxia (TAH) the conditions related to acute peri-
or postnatal asphyxia which did not fulfill all the
aforementioned criteria for HIE and where serial US
examinations never revealed structural impairment.
In TAH, likewise a transient ischaemic attack, partial
or complete brain hypoxia (and/or ischaemia) is fol-
lowedbycompletestructuralandfunctionalrecovery.
Newborns with NS were classified both with the
1989 classification Scheme and with the 2001 pro-
posed diagnostic scheme.
Etiology-specific therapy was given for seizures of
metabolic origin. An IV pyridoxine trial was per-
formed under EEG recording when seizures did
not stop after treatment with diazepam or pheno-
barbital IV, or phenytoin IV when seizures persisted.
Infants were followed up for a minimum of 2
months up to 13 years (mean 4 years and 1 month);
the results of the follow upwill be the subject future
study.3. Results
3.1. Clinical data
In the 94 infants, median gestational age (GA) was
38 weeks (range 25—42); median birth weight (BW)
was 2790 g (range 600—4090). Seventeen infants
had IUGR.
Neurological evaluation at the onset of seizures
was normal in seven cases; mildly/moderately
abnormal in 18 and severely abnormal in 49 infants.
Twenty infants could not be assessed as regards their
neurological status, being pharmacologically paral-
yzed at the onset of seizures. The results of neuro-
logical examination, EEG and neuro-imaging data
are shown in Table 1.
3.2. Characteristics of seizures
Seizures were first observed within 24 h from birth in
25% of patients and within 10 days in 76%. Seventy
infants (74%) had electro-clinical seizures: 50 (53%)
had also electrographic only seizures; 20 (21%) had
electrographic seizureswithout a corresponding clin-
ical seizure andwere pharmacologically paralyzed atthe onset of seizures; the remaining 4 (4%) had
electrographic only seizures but were not paralyzed.
Seizure duration was variable in each patient.
Sixteen infants (17%) had only seizures lasting less
than 1 min. Twenty-five (26%) had at least one
epileptic status.
Only 38 infants (40%) had one seizure type; most
had 2 or 3 types.
3.3. Short-term outcome
Twenty infants (21%) died before the end of the
neonatal period. After starting therapy, both elec-
trographic and electro-clinical seizures stopped
within 24 h in 46 infants (49%); in other 27 (28%) they
lastedmore than 1 day but less than 1 week; in 5 (5%)
they lastedmore than 1week and less than 30days. In
the remaining 16 infants (17%) seizures lasted more
than 30 days. At the end of the neonatal period
seizures were persisting in 19 infants (26% of the
survivors). Of the 25 infants with SE, 6 had seizures
persisting at the end of the neonatal period, 7 died.
Persistence of seizures at the end of neonatal
period, etiology underlying NS and incidence of
neonatal epileptic status are shown in Table 2.4. Classification
The 1989 classification is based on one hand on the
distinction among the epilepsies with generalized
seizures, those with partial seizures and the epilep-
sies and epileptic syndromes undetermined whether
focal or generalized. On the other hand, it further
divides the epilepsies of known etiology from the
idiopathic and cryptogenic epilepsies.
According to it, six newborns were classified
among neonatal epileptic syndromes (one with
BINNC, three with EME and two with EIEE), the
remaining 88 being classified as epilepsies and syn-
dromes undetermined whether focal or generalized.
The 2001 ILAE proposed diagnostic scheme9 is
meant toprovide thebasis for a standardizeddescrip-
tion of individual patients through five levels or axes.
Axis 1 describes the ictal semiology fromTheGlossary
of Descriptive Ictal Terminology15 but a standardized
terminology for newborns has not yet been accepted.
Axis II is the epileptic seizure type. Axis III defines the
syndromic diagnosis, whenever possible. Axis IV spe-
cifies aetiology, when known. Axis V, currently in
preparation, is meant to describe the degree of
impairment caused by the epileptic condition.
With this diagnostic scheme, the patient with
BINNC was classified under axis 3 as benign neonatal
seizures, a condition that do not require a diagnosis
of epilepsy; three patients with EME and the two
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Table 2 Etiology of seizures in our population (total number of infants (N), number below 35 weeks gestational age,
cases of epileptic status, deaths and persistence of seizures at the end of neonatal period (44weeks conceptional age).
Etiology N GA <35
weeks
Epileptic
status
Deceased Seizures at
44 weeks CA
HIE 42 24 9 10 6
CNS infection 10 4 2 5 2
CNS malformation 9 2 2 2 4
Metabolic 7 0 4 1 2
Stroke 7 0 1 0 0
TAH 6 1 0 0 0
Cryptogenic 5 0 1 0 5
Vascular 4 1 1 2 0
Transitory metabol 3 0 1 0 0
Idiopathic 1 0 1 0 0
Total 94 32 22 20 19
HIE, hypoxic ischaemic encephalopathy; CNS, central nervous system; TAH, transitory acute hypoxia; transitory metabol, transitory
metabolic abnormalities; GA, gestational age; CA, conceptional age.with EIEE were also classified under axis 3. Of these,
one patient with EME associated to non-ketotic
hyperglycinemia and 1 with EIEE associated to HIE
were also classified under axis 4. In the other three
cases etiology was cryptogenetic (symptomatic
unknown). Twenty patients died before the end of
the neonatal period. Out of the 74 survivors, 19
newborns had persistence of seizures at the end
of the neonatal period: 5 were the patients with EME
and EIEE; 4 had cerebral malformations and were
classified under axis 3 as focal symptomatic epilepsy
and under axis 4 as abnormal cortical development;
2 infants with cryptogenic seizures were classified
under axis 3 as probably symptomatic epilepsy. In
the remaining 8 infants, seizures, though related to
an acute condition (HIE in 5, cerebral infection in 2,
metabolic illness in 1), persisted beyond the acute
event till the end of the neonatal period and were
therefore classified under axis 3 as focal or multi-
focal symptomatic epilepsy and under axis 4 accord-
ing to the etiology of the disease.
In the other 55 patients, seizures had stopped
before the end of the neonatal period. According
to axis 3, one was classified as ‘‘benign neonatal
seizures’’ (BINNC in the1989 ILAEclassification)while
54 were classified as ‘‘Epileptic seizures that do not
require a diagnosis of epilepsy’’, being event-related
and subsiding soon after the acute event (Epilepsies
and syndromes undetermined as to whether they are
focal or generalized in the 1989 ILAE classification).5. Discussion
5.1. Diagnosis of neonatal seizures
In 1990 Shewmon, globally considering the problem
of NS, stated ‘‘Although epileptic seizures are morecommon in theneonatal period that at anyother time
of life, a standard operational definition of them is
lacking’’.16 The first question concerns diagnosis. A
seizure results when there is an excessive synchro-
nous electrical discharge of neurons within the cen-
tral nervous system.5 From a clinical point of view it
may be defined as a paroxysmal alteration in neuro-
logical function, i.e. behavioral, motor, and/or auto-
nomic function, associated temporally with EEG
seizure activity (electro-clinical seizure). In some
occasions this correlation is lacking (clinical-only
seizures) but it is not clear whether these latter
phenomena are related to an epileptic condi-
tion.4,5,10,16,17 On the other hand, electrical only
seizures are recognized4,18 and we observe electri-
cal-only seizures in severely ill newborns, whose
brain is damaged to the point that it cannot generate
a clinical phenomenon related to the electrical dis-
charge. Moreover, an electrical seizure may be the
result of a discharge arising from an area of the
cerebral cortex which does not express itself overtly
in the newborn, such as sensory or language areas.
Therefore, NS do not represent a homogeneous
clinical entity and it can be difficult to distinguish
epileptic from non-epileptic seizures when ictal
semiology is not EEG related. In 1987, Mizrahi e
Kellaway suggested to classify as ‘‘epileptic sei-
zures’’ only those paroxysmal events associated
with concurrent electrical seizure activity in the
EEG.10 Following these considerations, we took into
account, for the purposes of the study, only those
newborns whose seizures occurred in close associa-
tion with EEG ictal activity.10
5.2. Classification of seizures
Until nowmost child neurologists and neonatologists
based the classification of NS on ictal semiology.3,5
310 M. Mastrangelo et al.Since most of our patients had more than one
seizure type, classification of newborns with sei-
zures based on ictal semiology, as in the proposed
diagnostic scheme (axis 2) was not feasible.7 More-
over, axis 2 does not include seizure types unique to
the newborn such as subtle seizures. Moreover,
seizure types in newborns are not associated with
specific etiologies, within a syndrome, but rather
are related to the severity and extent of the cere-
bral injury.19,20 For instance, clonic seizures are
usually considered to have a good outcome, being
associated with focal structural lesions of the brain
such as focal infarction,5,10,13 but the outcome is
worse for those rarer focal clonic seizures asso-
ciated with a metabolic congenital disease or cor-
tical malformation.21
Most of our patients, besides those pharmacolo-
gically paralyzed, had also electrographic-only sei-
zures. The importance of electrographic seizures in
newborns with NS has been stressed by Mc Bride
et al.22 who found an association between electro-
graphic seizure activity and subsequent mortality
and morbidity. According to Mizrahi, electrographic
seizures are found in severely brain-damaged new-
borns and in those treated with muscle relaxant
agents or with AEDs (decoupled seizure activity),
after anticonvulsant treatment, particularly pheno-
barbital, has controlled the clinical seizures.10,12
Even considering only those who were not pharma-
cologically paralyzed, a high number of our new-
borns had electrographic seizures (54/74). It may be
that some of these were true electro-clinical sei-
zures whose minimal ictal manifestations were
missed at clinical inspection,12 but others are prob-
ably the result of the discharges arising in ‘‘silent’’
(age dependent) brain areas. In this respect we
think that to define the problem of semiology of
NS (axes 1 and 2), it is mandatory to consider only
newborns with ictal video EEG recordings.
5.3. Classification of newborns with NS
Recently, Arzimanoglou and Aicardi8 stated that
ILAE criteria for definition of syndromes are not
easily applicable to NS, and that it may be more
useful to consider the circumstances of clinical
presentation, particularly the neurological context.
The proposed diagnostic scheme of the ILAE com-
mission report (2001) offers the opportunity to
approach globally the problem of defining newborns
with seizures.
Along with Watanabe we think that some new-
borns with NS fit the definition of epilepsy as ‘‘a
condition with recurrent, unprovoked, ictal phe-
nomenology because of a more or less chronically
altered seizure threshold within an area or a neu-ronal system of the brain’’.7,23 In our study, 14/74
newborns (19% of the survivors) were still seizing at
the end of the neonatal period. Those with CNS
malformations and cryptogenic seizures were clas-
sified under axis 3 as focal symptomatic epilepsy and
probably symptomatic epilepsy respectively. In the
other 8 newborns, epilepsy was diagnosed because
seizures, though related to an acute condition (HIE
in 5, cerebral infection in 2, metabolic illness in 1),
were still persisting beyond the acute event till the
end of the neonatal period. They were therefore
classified under axis 3 as focal or multifocal sympto-
matic epilepsy and under axis 4 according to the
etiology of the disease.
It is common knowledge that etiology and the
degree of brain injury are the most important deter-
minants of outcome. However, this is only partially
true. In our group, not all newborns with sympto-
matic or cryptogenic seizures are epileptic. Conver-
sely, we disagree with Watanabe’s opinion7 that
seizures in newborns with HIE, intracranial haemor-
rhage, meningitis, encephalitis, must always be
classified as occasional seizures. Indeed, in some
of these newborns seizures were present at the end
of the neonatal period, far from the acute event. We
think that the evolution of the electro-clinical
course of seizures throughout the neonatal period
can provide for each patient an early diagnosis of an
epileptic condition that may be related to several
clinically different situations. Among our 54 new-
borns whose seizures were strictly event-related,
almost half (47%) were associated to HIE. Both in the
literature4,5,10,24,25 and in our population HIE was
the most frequent etiology associated to NS (45% in
our group).
HIE represents a heterogeneous clinical entity.
Outcome depends on severity, duration, the gesta-
tional age and the pathogenesis.26 All our patients
whose seizures were related to transitory acute
hypoxia did not have seizures at the end of the
neonatal period. Differently, the outcome of new-
borns with HIE-related seizures associated to a more
or less severe, focal or diffuse, cerebral injury is
more difficult to predict. Considering their high
correlation with neonatal epilepsy,27 later occur-
rence of epilepsy cannot be excluded in patients
with HIE who stopped seizing before the end of the
neonatal period. More data are needed in
asphyxiated newborns to detect risks factors, if
any, that could predict, early in the neonatal period,
the occurrence of post neonatal epilepsy.
5.4. Conclusions
Our data confirm that, with the new classification,
newborns with NS can be subdivided into more
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may be diagnosed already in the neonatal period7,11
supporting the choice of a long-term therapy. In
other newborns, NS are epileptic seizures but a
diagnosis of epilepsy needs not be made. However,
for a better understanding of newborns with sei-
zures, a sizable number of patients with homoge-
neous electro-clinical conditions, independently
from seizure type should be collected and grouped
according to the diagnosis (axes 3 and 4), to eval-
uate ictal and interictal EEG data in the three
different subgroups (neonatal epileptic encephalo-
pathy, partial neonatal epilepsy and epileptic sei-
zures that do not require a diagnosis of epilepsy), to
verify at long term follow up the global outcome and
the occurrence of epilepsy.- The proposed diagnostic scheme of the ILAE com-
mission report (2001) offers for the first time the
opportunity to approach globally the problem of
classification of newborns with seizures.- Axes 1 and 2 are the keys to define the clinical
characteristics of each seizure but until now they
cannot be applied to newborns with NS.- Axes 3 and 4 deal with classification of patients,
independently from seizure type.- Prognosis and therapeutic intervention could then
be provided according to the epileptological diag-
nosis (axes 3 and 4) independently from the sei-
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